Pharmaceutical Analysis & Statistics in Japan, January 2013 (p30)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

All regions

871-900 of about 1 200 reports

Purchase Reports From Reputable Market Research Publishers

Elvitegravir (HIV) - Forecast and Market Analysis to 2022

Elvitegravir (HIV) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • January 2013
  • by Global Data

Elvitegravir (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Elvitegravir (HIV) - Forecast and Market Analysis to 2022”. ...

  • Industries : Drug and Medication
  • Countries : Japan, Brazil, China, World, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Dolutegravir (HIV) - Forecast and Market Analysis to 2022

Dolutegravir (HIV) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • January 2013
  • by Global Data

Dolutegravir (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Dolutegravir (HIV) - Forecast and Market Analysis to 2022”. ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, China, United States, United Kingdom, Europe
572-Trii (HIV) - Forecast and Market Analysis to 2022

572-Trii (HIV) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • January 2013
  • by Global Data

572-Trii (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “572-Trii (HIV) - Forecast and Market Analysis to 2022”. Human I ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, China, United States, United Kingdom, Europe
Quad 2 (HIV) - Forecast and Market Analysis to 2022

Quad 2 (HIV) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • January 2013
  • by Global Data

Quad 2 (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Quad 2 (HIV) - Forecast and Market Analysis to 2022”. Human Immunodeficiency ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, China, United States, United Kingdom, Europe
Stribild (HIV) - Forecast and Market Analysis to 2022

Stribild (HIV) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • January 2013
  • by Global Data

Stribild (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Stribild (HIV) - Forecast and Market Analysis to 2022”. Human I ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, China, United States, United Kingdom, Europe
Complera (HIV) - Forecast and Market Analysis to 2022

Complera (HIV) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • January 2013
  • by Global Data

Complera (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Complera (HIV) - Forecast and Market Analysis to 2022”. Human I ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, China, United States, United Kingdom, Europe
Atripla (HIV) - Forecast and Market Analysis to 2022

Atripla (HIV) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • January 2013
  • by Global Data

Atripla (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Atripla (HIV) - Forecast and Market Analysis to 2022”. Human Immunodeficiency ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, China, United States, United Kingdom, Europe
Daiichi Sankyo Company, Ltd : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Report

Daiichi Sankyo Company, Ltd : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Report

  • $ 125
  • Company report
  • January 2013
  • by ICD Research

Synopsis ICD Research's "Daiichi Sankyo Company, Ltd : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. ...

  • Industries : Pathology
  • Countries : Japan
Pharma Clinical Trial Services: World Market 2013-2023

Pharma Clinical Trial Services: World Market 2013-2023

  • $ 2 401
  • Industry report
  • January 2013
  • by Visiongain

Report Details Discover new trends, opportunities and prospects for contract clinical trials What's the outlook for clinical research providers? Visiongain's updated report gives you forecasted revenues ...

  • Industries : Drug Discovery and Development
  • Countries : World, South Korea, Japan, India, Europe, China, Asia, United States, United Kingdom, Spain, Italy, France, Germany
Cytomegalovirus (CMV) Infections - Pipeline Assessment and Market Forecasts to 2019

Cytomegalovirus (CMV) Infections - Pipeline Assessment and Market Forecasts to 2019

  • $ 5 995
  • Industry report
  • January 2013
  • by Global Data

Cytomegalovirus (CMV) Infections - Pipeline Assessment and Market Forecasts to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, “Cytomegalovirus (CMV) Infections ...

  • Industries : Pathology
  • Countries : Japan, United States, Spain, Italy, France, Germany, World, United Kingdom
Statins Market to 2018 - Weak Product Pipeline and Shift of Focus towards Combination Therapies will Lead to Erosion of Brand Share

Statins Market to 2018 - Weak Product Pipeline and Shift of Focus towards Combination Therapies will Lead to Erosion of Brand Share

  • $ 3 500
  • Industry report
  • January 2013
  • by GBI Research

Statins Market to 2018 - Weak Product Pipeline and Shift of Focus towards Combination Therapies will Lead to Erosion of Brand Share Summary GBI Research, the leading business intelligence provider, has ...

  • Industries : Drug and Medication
  • Countries : Japan, World, Europe, United States
Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need

Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need

  • $ 3 500
  • Industry report
  • January 2013
  • by GBI Research

Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need Summary GBI Research, the leading business intelligence provider, ...

  • Industries : Pathology
  • Countries : Spain, Italy, France, Germany, Japan, World, Europe, United States, United Kingdom
The 2013-2018 Outlook for Pharmaceutical Preparations for Human Use Acting on the Cardiovascular System in Japan

The 2013-2018 Outlook for Pharmaceutical Preparations for Human Use Acting on the Cardiovascular System in Japan

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This econometric study covers the latent demand outlook for pharmaceutical preparations for human use acting on the cardiovascular system across the prefectures and cities of Japan. Latent demand (in millions ...

  • Industries : Pharmaceutical
  • Countries : Japan
The 2013-2018 Outlook for Vitamins in Japan

The 2013-2018 Outlook for Vitamins in Japan

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This econometric study covers the latent demand outlook for vitamins across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates ...

  • Industries : Vitamin and Supplement
  • Countries : Japan
The 2013-2018 Outlook for Vitamins and Dietary Supplements in Japan

The 2013-2018 Outlook for Vitamins and Dietary Supplements in Japan

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the latent demand outlook for vitamins and ...

  • Industries : Vitamin and Supplement
  • Countries : Japan
The 2013-2018 Outlook for 215 to 235-Pound Inorganic-Base Asphalt Strip Shingles Excluding Laminated Shingles in Japan

The 2013-2018 Outlook for 215 to 235-Pound Inorganic-Base Asphalt Strip Shingles Excluding Laminated Shingles in Japan

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the latent demand outlook for 215 to 235-pound ...

  • Industries : Pathology
  • Countries : Japan
The 2013-2018 Outlook for 235 to 240-Pound Organic-Base Asphalt Strip Shingles Excluding Laminated Shingles in Japan

The 2013-2018 Outlook for 235 to 240-Pound Organic-Base Asphalt Strip Shingles Excluding Laminated Shingles in Japan

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the latent demand outlook for 235 to 240-pound ...

  • Industries : Basic Chemical, Pathology
  • Countries : Japan
The 2013-2018 Outlook for Absorbent and Packing Gauze Surgical Dressings in Japan

The 2013-2018 Outlook for Absorbent and Packing Gauze Surgical Dressings in Japan

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the latent demand outlook for absorbent and ...

  • Industries : Over-the-counter Drug
  • Countries : Japan
The 2013-2018 Outlook for Ace Inhibitor Vasodilator Pharmaceuticals in Japan

The 2013-2018 Outlook for Ace Inhibitor Vasodilator Pharmaceuticals in Japan

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the latent demand outlook for ace inhibito ...

  • Industries : Drug and Medication
  • Countries : Japan
The 2013-2018 Outlook for Acetaminophen (paracetamol) in Japan

The 2013-2018 Outlook for Acetaminophen (paracetamol) in Japan

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the latent demand outlook for acetaminophen ...

  • Industries : Drug and Medication
  • Countries : Japan
The 2013-2018 Outlook for Acetaminophen and Acetaminophen Combinations in Japan

The 2013-2018 Outlook for Acetaminophen and Acetaminophen Combinations in Japan

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the latent demand outlook for acetaminophen ...

  • Industries : Over-the-counter Drug
  • Countries : Japan
The 2013-2018 Outlook for Alimentary and Metabolism Pharmaceuticals in Japan

The 2013-2018 Outlook for Alimentary and Metabolism Pharmaceuticals in Japan

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the latent demand outlook for alimentary and ...

  • Industries : Pharmaceutical
  • Countries : Japan
The 2013-2018 Outlook for Allergy Medicine in Japan

The 2013-2018 Outlook for Allergy Medicine in Japan

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the latent demand outlook for allergy medicine ...

  • Industries : Drug and Medication
  • Countries : Japan
The 2013-2018 Outlook for Allergy-Relieving Eye Drops in Japan

The 2013-2018 Outlook for Allergy-Relieving Eye Drops in Japan

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the latent demand outlook for allergy-relieving ...

  • Industries : Drug Delivery Technology
  • Countries : Japan
The 2013-2018 Outlook for Analgesics in Japan

The 2013-2018 Outlook for Analgesics in Japan

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the latent demand outlook for analgesics across ...

  • Industries : Drug and Medication
  • Countries : Japan
The 2013-2018 Outlook for Antacid Pharmaceutical Preparations Excluding Effervescent Salicylate Analgesics in Japan

The 2013-2018 Outlook for Antacid Pharmaceutical Preparations Excluding Effervescent Salicylate Analgesics in Japan

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the latent demand outlook for antacid pharmaceutical ...

  • Industries : Drug and Medication
  • Countries : Japan
The 2013-2018 Outlook for Antacids in Japan

The 2013-2018 Outlook for Antacids in Japan

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the latent demand outlook for antacids across ...

  • Industries : Drug and Medication
  • Countries : Japan
The 2013-2018 Outlook for Anti-Acne Dermatological Skin Preparations in Japan

The 2013-2018 Outlook for Anti-Acne Dermatological Skin Preparations in Japan

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the latent demand outlook for anti-acne dermatological ...

  • Industries : Drug and Medication
  • Countries : Japan
The 2013-2018 Outlook for Anti-Arrhythmic Vasodilator Pharmaceuticals in Japan

The 2013-2018 Outlook for Anti-Arrhythmic Vasodilator Pharmaceuticals in Japan

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the latent demand outlook for anti-arrhythmic ...

  • Industries : Pharmaceutical
  • Countries : Japan
The 2013-2018 Outlook for Anticoagulant Pharmaceutical Preparations in Japan

The 2013-2018 Outlook for Anticoagulant Pharmaceutical Preparations in Japan

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the latent demand outlook for anticoagulant ...

  • Industries : Drug and Medication
  • Countries : Japan

14 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Novartis Inc.

Switzerland

Abbott Laboratories

United States

GlaxoSmithKline PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.